Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > TBP Green with Double the Average Volume Friday

<< Previous

Bullboard Posts

Next >>

Post by Savage97on Feb 26, 2022 10:29pm

228 Views

Post# 34465185

TBP Green with Double the Average Volume Friday

Institutional investors were loading up last week but was it due to their 3 press releases including TBP will be GENERATING INCOME or do they know that the DIN # is on the way. GLTA

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?